|
|
|
|
||
CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine CandidateCEPI to invest an additional $66m upfront in Clover’s S-Trimer protein vaccine candidate. Funding will support clinical development in parallel with scale-up of manufacturing capacity to potentially produce hundreds of millions of doses per year. July 08, 2020 04:00 AM Eastern Daylight Time More detail at link below: https://www.businesswire.com/news/home/20200708005325/en/CEPI-Expands-Partnership-Clover-Biopharmaceuticals-Rapidly-Advance |
return to message board, top of board |